Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Antiviral Therapy|April 6, 2013
The role of natural killer cells in hepatitis C infectionJessica Howell, Kumar VisvanathanHepatology International|August 12, 2009
New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune responseDilip Ratnam, Kumar VisvanathanAntiviral Therapy|June 21, 2011
Polymorphisms of toll-like receptors and their pathways in viral hepatitisRohit Sawhney, Kumar VisvanathanSeminars in Liver Disease|May 5, 2006
Immunopathogenesis: role of innate and adaptive immune responsesKumar Visvanathan, Sharon R LewinDiscovery Medicine|August 14, 2010
Drug targets in immunological diseases: Focus on rheumatoid arthritisAndrew D Cook, Kumar VisvanathanJournal of Gastroenterology and Hepatology|July 30, 2009
Toll-like receptors and their role in gastrointestinal diseaseAdam G Testro, Kumar VisvanathanExpert Opinion on Therapeutic Targets|October 8, 2004
Molecular targets in immune-mediated diseases: focus on rheumatoid arthritisAndrew D Cook, Kumar VisvanathanAntiviral Therapy|August 6, 2011
Antiviral therapy for hepatitis B infection during pregnancy and breastfeedingMichelle Giles, Kumar Visvanathan, Joe SasadeuszGastroenterology Research and Practice|April 5, 2012
HIV Infection and TLR Signalling in the LiverMegan Crane, Kumar Visvanathan, Sharon R LewinCellular Immunology|November 6, 2012
Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis BDilip T Ratnam, William Sievert, Kumar VisvanathanPageof 8